Scripius, a pharmacy benefit manager committed to transparency and affordability, issued the following statement in response to Congress’s bipartisan approval of legislation aimed at strengthening transparency and oversight within the pharmacy benefit manager system:
Scripius welcomes congressional action to improve transparency and accountability in how prescription drug benefits are administered. Increased visibility into PBM practices is an important step toward restoring trust, improving affordability, and ensuring decisions are guided by what is best for consumers.
The legislation reflects practices Scripius has embraced since its inception—advancing transparency and helping connect our members to effective, high-quality treatment and care. Clearer reporting and oversight support a more straightforward, value-driven approach to prescription drug management.
“Greater transparency is critical to building a system that truly serves consumers, and it’s encouraging to see steps taken to change how prescription drug benefits are managed,” said Eric Cannon, chief commercial officer and general manager of Scripius. “We appreciate the bipartisan effort to address long-standing concerns and advance reforms that align with the work Scripius has been focused on for years—improving clarity, removing barriers, and helping people access the care and medications they need.”
